Results 111 to 120 of about 86,609 (293)

Angiogenesis-dependent and independent phases of intimal hyperplasia. [PDF]

, 2004
BACKGROUND: Neointimal vascular smooth muscle cell (VSMC) proliferation is a primary cause of occlusive vascular disease, including atherosclerosis, restenosis after percutaneous interventions, and bypass graft stenosis. Angiogenesis is implicated in the
Bhardwaj, S, De Muinck, E, Ferrara, N, Khurana, R, Martin, JF, Murakami, M, Simons, M, Yla-Herttuala, S, Zachary, I, Zhuang, Z   +9 more
core   +1 more source

Paclitaxel‐Coated Balloons for Femoropopliteal Artery Disease Treatment in French Patients: A Longitudinal Observational Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Clinical studies have demonstrated the safety and effectiveness of drug‐coated balloon (DCB) angioplasty for femoropopliteal revascularization. Long‐term studies in routine practice are limited. Aims The aim of this study was to assess long‐term outcomes after DCB angioplasty for femoropopliteal peripheral artery disease in a real ...
Yann Gouëffic, Maxime Dubosq‐Lebaz, Jean‐François Heautot, Aurore Tricotel, Antoine Sauguet   +4 more
wiley   +1 more source

Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber [PDF]

, 2012
Coronary stent design influences local patterns of wall shear stress (WSS) that are associated with neointimal growth, restenosis, and the endothelialization of stent struts.
Gundert, Timothy J, LaDisa, John F., Marks, David S., Marsden, Alison L., Yang, Weiguang   +4 more
core   +1 more source

The Hybrid Approach to Intervention of Chronic Total Occlusions [PDF]

, 2015
The "hybrid" approach to chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was developed to provide guidance on optimal crossing strategy selection.
Banerjee, S, Brilakis, ES, Christopoulos, G, Kotsia, A, Rangan, BV, Rinfret, S, Spratt, J   +6 more
core   +1 more source

Efficacy and Safety of Intravascular Lithotripsy in the Management of Underexpanded Stents: A Systematic Review and Meta‐Analysis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Stent underexpansion significantly heightens the risk of major adverse cardiac events (MACE), and available treatment options for this condition remain limited. Intravascular Lithotripsy (IVL) technology disrupts superficial and deep calcium by using localized pulsative sonic pressure waves, emerges as a promising tool for ...
Marios Sagris, Stergios Soulaidopoulos, Angelos Papanikolaou, Nikolaos Ktenopoulos, Martijn J. H. van Oort, Jose M. Montero‐Cabezas, Nikolaos Patsourakos, Benjamin Honton, Dimitris Tousoulis, Konstantinos Tsioufis   +9 more
wiley   +1 more source

Coronary In-Stent Restenosis: JACC State-of-the-Art Review.

Journal of the American College of Cardiology, 2022
G. Giustino, A. Colombo, A. Camaj, K. Yasumura, R. Mehran, G. Stone, A. Kini, Samin K. Sharma   +7 more
semanticscholar   +1 more source

Small poly-L-lysines improve cationic lipid-mediated gene transfer in vascular cells in vitro and in vivo [PDF]

, 2007
The potential of two small poly-L-lysines ( sPLLs), low molecular weight sPLL ( LMW-L) containing 7 - 30 lysine residues and L18 with 18 lysine repeats, to enhance the efficiency of liposome-mediated gene transfer ( GT) with cationic lipid DOCSPER {[}1,3-
Adam Golda, Armeanu S, Bauters C, Boussif O, Capan Y, Choukri Mekkaoui, Eastman SJ, Gao X, Groth D, Guenzburg WH, Hofling B, Huehns TY, Huehns TY, Jaroslav Pelisek, Khalil IA, Li S, Mahato RI, Markus G. Engelmann, Miller AD, Nikol S, Nikol S, Nikol S, Nikol S, Nikol S, Ogris M, Pelisek J, Pelisek J, Pelisek J, Pelisek J, Pierre-Henri Rolland, Rainer Klocke, Shi Y, Sigrid Nikol, Sorgi FL, Vitiello L, Wadhwa MS, Wolfert MA   +36 more
core   +1 more source

Delayed Restenosis after Gamma Brachytherapy for In‐Stent Restenosis

Journal of Interventional Cardiology, 2004
Intracoronary brachytherapy is a promising modality for inhibition of in‐stent restenosis. However, there is a concern of late progression after brachytherapy. This case report describes delayed restenosis after brachytherapy.
Yoshio Kobayashi, Jeffrey W. Moses, Makoto Hirose   +2 more
openaire   +3 more sources

The First‐in‐Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Treating ostial left circumflex artery (LCx) lesions in percutaneous coronary intervention (PCI) for left main disease (LMD) remains a challenge. Despite recent recommendations for the use of drug‐coated balloon (DCB) in this lesion, there are concerns about crossover‐stenting from the left main trunk (LMT) to the left anterior ...
Takayuki Warisawa, Yoshiki Kawai, Takuya Matsumoto, Shingo Sato, Makoto Takeyama, Yuta Nakamura, Susumu Katsushika, Aritomo Katsura, Takahiro Sato, Masashiro Matsushita, Jiro Ando   +10 more
wiley   +1 more source

Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients

Vascular Health and Risk Management, 2023
Cynthia Al Hageh,1,* Stephanie Chacar,2,* Thenmozhi Venkatachalam,2 Dominique Gauguier,3,4 Antoine Abchee,5 Elie Chammas,6 Hamdan Hamdan,2 Siobhan O’Sullivan,1 Pierre Zalloua,1,7,8 Moni Nader2,7 1Department of Molecular Biology and Genetics ...
Al Hageh C, Chacar S, Venkatachalam T, Gauguier D, Abchee A, Chammas E, Hamdan H, O'Sullivan S, Zalloua P, Nader M   +9 more
doaj